Numerous models have been developed to predict remission in rheumatoid arthritis (RA) based on regressionbased statistical approaches, but these models seldom address newer therapies or remission assessed over longer follow-up periods.Machine learning-based models may enable the discovery of complex, nonlinear interactions across diverse variables. SUMMARYObesity and overweight are common comorbidities in people living with psoriatic arthritis (PsA), affecting up to provides a new avenue to improve outcomes in PsA. and followed them for 3-12 months.Over this time period, researchers found that patients taking these medications also served as an added way to reduce pain and improve cardiometabolic markers, highlighting the importance of addressing obesity in the treatment of PsA.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: